Safety of AFM11 in the treatment of patients with B-cell malignancies: findings from two phase 1 studies

Erstveröffentlichung

2023

Authors

Topp, Max

Dlugosz-Danecka, Monika

Skotnicki, Aleksander B.

Salogub, Galina

Viardot, Andreas

et al.

Wissenschaftlicher Artikel

Published in

Trials ; 24 (2023). - Art.-Nr. 4. - eISSN 1745-6215

Link to publication

https://dx.doi.org/10.1186/s13063-022-06982-7

Institutions

UKU. Klinik für Innere Medizin III

Subject headings

[Free subject headings]: Non-Hodgkin lymphoma | Acute lymphoblastic leukaemia | AFM11 | Neurotoxicity | T-cell engager | ACUTE LYMPHOBLASTIC-LEUKEMIA | BLINATUMOMAB | ADULTS | TARGET | CD19
[DDC subject group]: DDC 610 / Medicine & health

Metadata

Show full item record